Burden of RA attributable to smoking in 2021 across 204 countries and territories. by Kaibin Lin (9911049)

Subjects:

Sex and age differences in smoking-attributable RA burden in 2021. by Kaibin Lin (9911049)

Subjects:

Smoking-Attributable RA Burden from 2000 to 2021: Global Temporal Trends and Regional Differences in Smoking Prevalence and Burden Indicators. by Kaibin Lin (9911049)

Subjects:

Relationship between SDI and smoking-attributable RA burden. by Kaibin Lin (9911049)

Subjects:

Effect of preplant treatments (a) and post-plant treatments (b) on anthracnose fruit rot (AFR) fruit biomass during the 2022/23 and 2023/24 growing seasons. by Baker D. Aljawasim (22765921)

LDH expression is a surrogate for cell death. by Bryan S. Margulies (21492667)

Table 1_Centella asiatica enhances diabetic wound healing by decreasing macrophage-driven inflammation via the AKT/MAPK/NF-κB pathway.xlsx by Fugang Xiao (22152127)

The Drop-off Locations of Taxis for a Morning Peak Period: (a) Head taxis; (b) All taxis. by Fangyi Yang (18867853)

Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients. by Jia Song (495396)

Genes show significant expression change in meta-analysis and their connection with Sjogren’s syndrome and thyroid cancer. by Fanyong Kong (20700261)

“…A gene in red indicates significantly increased expression in the meta-analysis, whereas a gene in blue indicates significantly decreased expression in the meta-analysis.…”

Fig 6 - by Teagan McMahon (20108036)

DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

“…</p><p>Results</p><p>From 2019 to 2023, the DDDs of rivaroxaban demonstrated a significant annual increase in most hospitals (<i>p</i> < 0.05). …”

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

The ANCOVA and Post_hoc results. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

Time to stabilization in the vertical direction. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

The description of games. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

The description of balance training. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”